University of Miami
Miami, Florida, 33136, United States
Location status: Recruiting
Location contact
Mariano Kanamori, PhD
CONTACT
Mariano Kanamori, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06406049
This study aims to learn how to help enable healthy behaviors and lower the risk of HIV among Latinx Men.
Interested in participating?
Request Info18 year–54 year
Male
Interventional
Not applicable
Miami, Florida, 33136, United States
Location status: Recruiting
Mariano Kanamori, PhD
CONTACT
Mariano Kanamori, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive the standard of care (beginning of the study) which includes sexual health information once in-person for up to 15 minutes for the duration of the study.
Participants will come to the study location for up to 2 hours three times (beginning of the study, 6-month and 12-month follow-ups) during the duration of the study. During the study, participants will receive sexual health counseling for HIV prevention. Additionally participants will receive information and resources for PrEP usage. Participants will be encouraged to share sexual health information two times (three and nine months after the beginning of the study) during the duration of the study.
Time frame: Up to 12-months
PrEP initiation will be measured by analyzing the number of participants that initiate PrEP divided by the total number of participants
Time frame: Up to 12-months
PrEP initiation will be measured by analyzing the number of DBS tests that report PrEP use divided by the total number of participants
Time frame: Up to 12-months
PrEP initiation will be measured by analyzing the number of participants that bring proof of a PrEP prescription divided by the total number of participants
Time frame: Up to 12-months
Scores range from 1 (I don't know) to 5 (99% or more than 99% effective). Higher scores indicate adequate PrEP knowledge.
Time frame: Up to 12-months
PrEP adherence will be measured by analyzing the number of DBS tests that report PrEP adherence divided by the total number of participants that initiate PrEP during the study
Contact information is provided by the study sponsor or research team.
University of Miami
Other
FINISHING HIV: An Ending the HIV Epidemic (EHE) Model for Latinx Integrating One-Stop-Shop Pre-Exposure Prophylaxis (PrEP) Services, a Social Network Support Program and a National Pharmacy Chain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05419024
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Bethesda, Maryland, United States
View Trial DetailsNCT00006518
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Bethesda, Maryland, United States
View Trial DetailsNCT06666322
Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses
Kampala, Uganda
View Trial DetailsNCT00001316
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Bethesda, Maryland, United States
View Trial Details